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ALTHOUGH airway  inflammation  and  airway  hyper-
reactivity are observed after allergen inhalation both
in allergic humans and animals, little is known about
the  mechanisms  by  which  inflammatory  cells  can
contribute  to  allergen-induced airway  hyperreactiv-
ity. To understand how inflammatory cell infiltration
can contribute to airway hyperreactivity, the location
of these cells within the airways may be crucial.
Using a guinea pig model of acute allergic asthma,
we investigated the inflammatory cell infiltration in
different airway compartments at 6 and 24h (i.e. after
the  early  and  the  late  asthmatic  reaction,  respec-
tively) after allergen or saline challenge in relation to
changes in airway reactivity (AR) to histamine.
At 6h after allergen challenge, a threefold (p < 0.01)
increase in the AR to histamine was observed. At 24h
after challenge, the AR to histamine was lower, but
still significantly enhanced (1.6-fold, p < 0.05).
Adventitial eosinophil and neutrophil numbers in
both  bronchi  and  bronchioli  were  significantly
increased  at  6h  post-allergen  provocation  as  com-
pared with saline (p < 0.01 for all), while there was a
strong  tendency  to  enhanced  eosinophils  in  the
bronchial submucosa at this time point (p = 0.08). At
24h  after  allergen  challenge,  the  eosinophilic  and
neutrophilic  cell  infiltration  was  reduced.  CD3+ T
lymphocytes  were increased in the adventitial com-
partment of the large airways (p < 0.05) and in the
parenchyma  (p <  0.05)  at  24h  post-allergen,  while
numbers  of  CD8+ cells  did  not  differ  from  saline
treatment at any time point post-provocation.
The  results  indicate  that,  after  allergen  provoca-
tion,  inflammatory  cell  numbers  in  the  airways
are mainly elevated in the adventitial compartment.
The  adventitial  inflammation  could  be  important
for  the  development  of  allergen-induced  airway
hyperreactivity.
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Introduction
Allergic asthma in man is clinically characterized by
bronchoconstriction  in  response  to  inhaled  aero-
allergens,  resulting  in  an  early  asthmatic  reaction
(EAR)  that  is  often  followed  by  a  late  asthmatic
reaction (LAR). The EAR is thought to be  primarily
caused by an immunoglobulin (Ig)E-mediated release
of mast cell mediators, while the LAR is associated
with the recruitment and activation of inflammatory
cells in the lung, including  eosinophils, neutrophils
and lymphocytes.1–4
Another important feature of allergic asthma is the
development of increased reactivity of the airways to
non-specific  stimuli  following  allergen  exposure,
referred to as airway hyperreactivity (AHR). Allergen-
induced AHR has been observed in patients with a
dual asthmatic reaction, and may already be present
before the onset of the LAR.5–8 It is generally thought
that  inflammatory  cell  influx  in  the  airways  is
involved in the development of AHR. However, a close
relationship  between  the  number  of  inflammatory
cells in the airway lumen or mucosa and chronic AHR
has not invariably been found, which may possibly be
due  to  airway  remodeling  after  prolonged
inflammation.9–11
Although information from biopsy studies is avail-
able  about  inflammation  in  the  airway  wall  of
asthmatics, little is known about the distribution of
inflammatory  cells  throughout  the  entire  airway
circumference  and  lung  tissue  of  these  patients.
Detailed knowledge  about  this  distribution  may  be
ISSN 0962-9351 print/ISSN 1466-1861 online/01/030143-12 © 2001 Taylor & Francis Ltd 143
DOI: 10.1080/09629350120072716
Research Paper
Mediators of Inflammation, 10, 143–154 (2001)pivotal  to  understanding  the  role  of  inflammatory
cells in the development of AHR. Techniques to assess
airway  inflammatory  cell  distribution  in  relation to
AHR in asthmatic patients are limited: biopsy samples
can only be collected from superficial layers of larger
proximal  airways,  which  provide  no  information
about  deeper  peribronchial  areas  nor  about  more
distal smaller airways. In addition, cells obtained from
bronchoalveolar lavage (BAL) and sputum induction
represent  primarily  luminal  inflammation.  Detailed
histopathologic studies of the airways from patients
with  fatal  and  non-fatal  asthma  with  respect  to
inflammatory cell distribution within and along the
airways  have  been  performed,12–17 but  cannot  be
quantitatively related with AHR.
The aim of the present study was to investigate the
distribution of the inflammatory infiltrate both within
the airway wall (i.e. the adventitia and submucosa)
and between the central and peripheral airways and
the parenchyma in relation to AHR after the allergen-
induced EAR  and LAR. To this purpose, we used a
guinea  pig  model  of  allergic  asthma  with  great
qualitative  and  quantitative  similarities  in  allergen-
induced EAR, LAR and AHR after both reactions, and
airway  inflammation  as  assessed by  BAL  compared
with asthmatic patients.18
Materials and methods
Animals
Specified  pathogen-free  tri-colored  bastard  male
guinea pigs (Charles River; SAVO, Kiszlegg, Germany)
weighing 400–500g were actively sensitized to oval-
bumin as described previously.19 To obtain a shift to
IgE class antibodies, an allergen solution containing
100 m g of ovalbumin and 100mg of Al(OH)3 perml
saline  was  used. The  allergen  solution  was  gently
rotated for 60min to obtain an alu-gel, and 0.5ml was
injected intraperitoneally,  while  another 0.5ml  was
divided over seven intracutaneous injection sites in
the proximity of lymph nodes in the paws, lumbar
regions and neck. Animals were operated on 3 weeks
after sensitization and used experimentally 4–8 weeks
after  sensitization.  The  animals  were  housed  in
individual cages in climate-controlled animal quarters,
and  were  given  water  and  food  ad  libitum.  All
protocols described were approved by the University
of Groningen Animal Ethical Committee.
Measurement of airway function
Airway function was assessed by  measuring pleural
pressure (Ppl) as described previously.20 In short, a
small saline-filled latex balloon connected to a saline-
filled canula was surgically implanted in the thoracic
cavity. The free end of the canula was subcutaneously
driven to the neck of the guinea pigs, where it was
exposed and attached permanently. The canula was
connected to a pressure transducer (Ohmeda DTX™;
SpectraMed,  Bilthoven, The  Netherlands)  using  an
external saline-filled canula. Ppl (cmH2O) was meas-
ured continuously using an on-line computer system.
We  have previously  shown that changes  in  Ppl are
linearly correlated to changes in airway resistance and
hence can be used as a sensitive index for allergic and
non-allergic  bronchoconstriction.20 In  this  way,  air-
way  function  can  be  monitored  repeatedly  and
continuously for prolonged periods of time, while the
animals  are  unaware  of  the  measurements  being
taken.
Provocation procedures
Ovalbumin  and  histamine  provocations  were  per-
formed  by  inhalation  of  aerosolized solutions,  pro-
duced by a DeVilbiss nebulizer (type 646; DeVilbiss,
Somerset,  PA,  USA),  with  an  airflow  of  8l/min
resulting  in an output  of  0.33ml/min.  Provocations
were carried out in a specially designed perspex cage
(internal volume, 9l) in which the guinea pigs could
move freely.
Before  the  start  of  the  experiment,  the  animals
were habituated to the experimental conditions and
the provocation procedures on two sequential days at
least 1 week after surgery, when preoperative weight
was  restored.  On  the  first  day,  the  animals  were
placed in the provocation cage unconnected to the
pressure transducer. After an adaptation period of at
least  30min,  three  consecutive  provocations  with
saline  were  performed,  each  provocation  lasting
3min and separated by a 7min interval. The next day,
this procedure was repeated with the animals con-
nected to the measurement system
During  the  experimental  protocol  following  the
habituation  procedure,  all  provocations  were  pre-
ceded by a 30min adaptation period and followed by
two  consecutive  control  provocations  with  saline
(3min) as already described. A baseline Ppl value was
calculated by averaging the Ppl values from the last
20min of the adaptation period.
To  assess  the  airway  reactivity  for  histamine,
histamine provocations were started with a solution
containing 25 m g/ml of histamine in saline, followed
by  increasing  dosage  steps  of  25 m g/ml.  Histamine
provocations lasted 3min, separated by 7min inter-
vals. Animals were challenged until Ppl was increased
by more than 100% above baseline, for at least three
consecutive minutes. Ppl returned to baseline value
within  15min  after  the  last  histamine  provocation.
The airway reactivity (AR) to histamine was expressed
as the concentration causing a 100% increase in Ppl
(PC100), which was calculated by linear intrapolation
of the concentration-Ppl response curve. Changes in
AR  towards  histamine  were  expressed  as  the  ratio
PC100 pre/post allergen challenge.
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tion  of  increasing  concentrations  of  1.0,  3.0  and
5.0mg/ml  of  ovalbumin  in  saline  for  3min  each,
separated  by  7min  intervals.  Allergen  inhalations
were discontinued when an increase in Ppl of 100% or
more was observed. Using these conditions, none of
the animals developed anaphylactic shock after aller-
gen provocation. For the quantitative assessment of
the EAR and LAR, airway function was continuously
measured  up  to  24h  after  allergen  challenge. The
magnitudes  of  the  allergen-induced  EAR  and  LAR
were  expressed  as  the  area  under  the  Ppl time-
response  curve  (AUC)  between  0  and  6h  after
allergen provocation for the EAR, and between 8 and
24h after provocation for the LAR. Ppl was expressed
as the percentage change from baseline, and AUC was
calculated  by  trapezoid  integration  over  discrete
(5min) time periods. Based on saline control provoca-
tions, threshold values of AUC (mean +  2  SD; 99%
confidence interval) were defined as 1185% ´ 5min
for a positive early response and 2790% ´ 5min for a
positive late response, respectively.18
Histamine PC100 values were assessed 24h before,
and 6h (after the EAR) and 24h (after the LAR) after
ovalbumin  provocation.  Inhalations  with  saline
instead of  ovalbumin  served as controls. For tissue
sampling, animals were terminated at 6.5h (group 1)
or  at  24.5h  (group  2)  after  ovalbumin  or  saline
provocation.
Tissue processing
Guinea pigs were killed by cervical dislocation, after
which the lungs were immediately resected and kept
on  ice  in  a  petri  dish  during  further  processing.
Additionally, the spleen was removed for qualitative
assessment of antibody specificity. The superior and
median lobes of the right lung and the spleen were
snap frozen at –80°C in isopentane, and tissue was
stored  at  –80°C.  Frozen  sections  were  cut  at  a
thickness of 4 m m and stored, wrapped in aluminium
foil, at –20°C until use (within 2 weeks).
Inflammatory cell characterization
Inflammatory cells were identified using histochem-
ical and immunohistological techniques. Eosinophils
were  identified  using  hematoxylin–eosin  staining.
Neutrophils  were  identified  by  a  combination  of
morphologic criteria and tissue non-specific alkaline
phosphatase  enzyme  histochemistry,  as  described
previously.21
Infiltration of T cells in the lung was analyzed by
immunohistological  techniques  using  a  rabbit  anti-
human CD3 polyclonal antibody (Dakopatts Ltd, High
Wycombe,  UK)  as  a  pan  T-cell  antibody,  and  the
murine monoclonal CT6 as a CD8+ T-cell antibody22
(generously  provided  by  Prof.  R.J.  Scheper,  Free
University  of Amsterdam).  In  brief,  frozen  sections
were fixed at room temperature (RT) for 10min in
100%  acetone and  washed for  5min  in  phosphate-
buffered  saline  (PBS)  (pH  7.4).  To  prevent  non-
specific staining, the slides were incubated for 30min
with  10%  normal  goat  or  normal  rabbit  serum,
respectively, diluted in PBS. Then, the sections were
incubated  for  1h at  RT  with the primary  antibody
diluted (1:100 and 1:5000, respectively) in 1% bovine
serum albumin in PBS. After rinsing three times with
PBS for  5min,  endogenous  peroxidase activity was
blocked by incubating the slides in 0.075% hydrogen
peroxide in PBS for 30min. Following three washes
with PBS, the slides were incubated for 30min with
peroxidase-conjugated secondary  antibodies  (Dako-
patts,  Glosstrup,  Denmark),  diluted  in  2%  normal
guinea  pig  serum  in  PBS. A  peroxidase-conjugated
goat-anti-rabbit  IgG  antibody  (dilution  1:100)  was
used  for  the  detection of  the  CD3  polyclonal  anti-
bodies,  and  a  peroxidase-conjugated  rabbit-anti-
mouse IgG (dilution 1:50) was used for the detection
of the CT6 monoclonal antibodies. Next, the sections
were washed in PBS and the peroxidase activity was
developed in a freshly prepared solution of 3-amino-
9-ethylcarbazol, containing 0.03% hydrogen peroxide
for  10min.  Counterstaining  was  performed  using
Mayer’s  hematoxylin.  Antibody  specificity  was
checked by  incubating  adjacent lung  sections with
non-relevant  antibodies.  Guinea  pig  spleen  tissue
served as a positive control for specificity.
Cell quantification analysis
Using  a  light  microscope  (Olympus  BH-2,  Paes,
Zoeterwoude, The  Netherlands),  positively  stained
cells were enumerated in three anatomical areas as
indicated  in  Fig.  1.  The  numbers  of  eosinophils,
neutrophils,  total  T  cells  and  CD8+ T  cells  were
counted employing an eyepiece graticule comprising
100 squares of known area. The number of positive
cells present in the submucosa was expressed as cells
per millimeter of basement membrane. The length of
the  basement  membrane  was  estimated  using  the
formula derived from Buffons needle problem: Ba =
[(p /2)/IL] * d,23 where Ba is the length of the boundary
(mm), IL is the number of intersections formed by the
boundary with the parallel lines of the grid, and dis the
distance between two parallel grid lines (mm).
Adventitial cell counts were carried out in the same
airways.  Positive  cells  were  expressed  as  cells  per
millimeter of external smooth muscle perimeter. This
perimeter was also estimated using Buffons formula.
In the large airways, the adventitia was defined as the
area between the smooth muscle and the cartilage; in
the  small  airways,  the  adventitia  was  defined  as  a
50 m m  border  outside  and  directly  adjacent to  the
smooth muscle. In the parenchyma, positively stained
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Per  specimen,  at  least  three  large  and  three  small
airways  were  enumerated and,  in  the  parenchyma,
four random fields of 6.25 ´ 104 m m2 (the total area of
the graticule) were counted, and average values were
calculated per animal.
Statistical analysis
Statistical analysis on the magnitudes of the early and
the late asthmatic responses, and on the cell counts
between treatment groups, was performed using the
unpaired Mann–Whitney rank sum test. PC100 values
before and after allergen  challenge were  compared
using  a  one-way  analysis  of  variance.  When  sig-
nificance was observed (p < 0.05), a complementary
Student–Newman–Keuls  test  was  performed.  For
comparison of AHR  at  different  time  points  within
treatment  groups,  a Wilcoxon  signed-rank  test  was
used.
For the correlation between AHR and inflammatory
cells,  correlation  coefficients  and  p values  were
calculated  using  Spearman  rank  order  correlation
analysis.
Results
Ovalbumin-induced early and late asthmatic
reactions
Figure 2 shows a typical example of a dual asthmatic
reaction, induced by ovalbumin provocation. The EAR
starts with a sharp increase in Ppl, which is maximal
within  20min  and  lasts  2–4h.  The  LAR  starts  at
approximately 8h after allergen  provocation, being
reversible within 24h after the challenge. The airway
responses to allergen and saline control provocations
in animals terminated after the EAR and the LAR are
presented in Table 1.
Airway reactivity
Table 2 shows that an approximately threefold (p <
0.01) increase in AR to histamine was observed at 6h
after allergen provocation in both groups of animals,
while  a  smaller  but  still  significant AHR  (1.57-fold
increase, p < 0.05) was observed at 24h after allergen
challenge in the animals terminated after the LAR. No
change  in  airway  reactivity was observed in  saline-
challenged control animals.
Distribution of inflammatory cells in ovalbumin
and saline challenged animals
d Eosinophils. At  6h  after  allergen  provocation,  a
significant  fourfold  increase  in  eosinophils  was
observed in the adventitial layer of the bronchi (p
< 0.01;  Fig.  3A), whereas in the adventitial layer
of the bronchioli an eightfold increase in eosino-
phil  numbers  was  observed  at  the  same  time
point (p < 0.01;  Fig.  3C). The adventitial eosino-
phil  numbers  were  not  significantly  different
between  large  and  small  airways.  Twenty-four
hours after allergen challenge,  adventitial eosino-
phil  numbers  still  tended to be  elevated but  no
longer reached statistical significance. In the sub-
mucosal layer of the bronchi, eosinophils tended
to  be  enhanced  at  6h  after  allergen  exposure
compared with saline (p = 0.08; Fig. 3B), while at
24h post-allergen submucosal eosinophil numbers
did  not  differ  from  controls.  In  addition,  no
significant change was observed in the eosinophil
number of  the bronchiolar submucosa (Fig.  3D).
Furthermore,  in  the  parenchyma,  no  changes  in
eosinophil numbers were observed either at 6 or
24h  after  allergen  (Fig.  3E).  Cell  numbers  in
saline  treated  groups  did  not  differ  from  one
another at any time point.
d Neutrophils. At  6h  after  ovalbumin  provocation,
neutrophil numbers were significantly elevated in
the adventitia of the bronchi (p < 0.01; Fig. 4A) as
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FIG. 1. Anatomical areas studied in counting cellular infiltrates. In the parenchyma, random fields were counted, well away
from the airway. Adventitia, area between the smooth muscle layer and cartilage, or in the absence of cartilage, in a 50m m layer
adjacent to the outer edge of the smooth muscle; submucosa, area between the basement membrane and the inner perimeter
of the smooth muscle layer.well as in the bronchioli (p < 0.01; Fig. 4C). Twenty-
four  hours  after  allergen  exposure,  some  neu-
trophils were still present in the adventitia of the
large  airways,  but  these  numbers  were  not  sig-
nificantly  different  from  the  saline-treated group
(Fig.  4A). Few neutrophils were observed in the
submucosal compartment of both large and small
airways,  after  allergen  provocation  (Fig.  4B,D,
respectively);  however,  no significant  differences
were  observed  compared  with  saline.  No  neu-
trophils were present in the submucosal compart-
ment at any time point post-saline. Figure 4E shows
that  neutrophil  numbers  were  not  significantly
elevated in the parenchyma at any time point post-
Inflammatory cell distribution and airway reactivity
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FIG. 2. Representative example of a dual asthmatic response after allergen provocation of an ovalbumin-sensitized guinea pig
(thick line). The thin line represents the result of a saline control challenge. Provocations were performed at 0h.
Table 1. Airway responses of sensitized guinea pigs after saline inhalation or ovalbumin provocation
Group Inhalation AUC (% ´ 5min)
EAR (n) LAR (n)
1 Saline 47 ± 203 (6) –
Ovalbumin 3553 ± 1156* (6) –
2 Saline 135 ± 862 (4) 420 ± 873 (4)
Ovalbumin 3071 ± 317† (6) 9038 ± 2545* (4)
Data are presented as area under the percent change in Ppl time-response curve (AUC) between 0 and 6h after the allergen provocation for the
early asthmatic reaction (EAR) and between 8h and 24h after allergen provocation for the late asthmatic reaction (LAR). Results represent mean
values ± SEM of (n) animals. Group 1, guinea pigs terminated after the EAR; group 2, guinea pigs terminated after the LAR.
*p < 0.05, † p < 0.01 compared with saline inhalation, Mann–Whitney rank sum test.allergen  provocation  as  compared  with  saline-
treated animals.
d T-lymphocytes.  CD3+ T-cell  numbers  showed  no
quantitative changes at 6h after allergen provoca-
tion in any of the compartments investigated in the
allergen-treated group as compared with controls
(Fig.  5A–E). At  24h,  however,  CD3+ cells  were
increased in both the adventitial layer of the large
airways  (p <  0.05)  and  in  the parenchyma  (p <
0.05), as is shown in Fig. 5A,E, respectively. CD8+T
cells  showed  no  significant  change  at  any  time
point, after either ovalbumin  or saline treatment
(not shown).
For  all  cell  numbers,  no  significant  differences
between large and small airways were observed.
No  significant  correlations  between  allergen-
induced cell infiltration in the different compartments
and AHR were observed, except for CD3+ cells in the
parenchyma at 24h after ovalbumin (r = 0.89,  p <
0.05).
Discussion
In  a  guinea  pig  model  of  allergic  asthma,  charac-
terized by allergen-induced EAR, LAR and AHR after
both reactions, we have explored the infiltration of
eosinophils, neutrophils,  and T  lymphocytes  in  the
submucosal  and  adventitial  compartments  of  large
(cartilaginous) and small (non-cartilaginous) airways
at  6  and  24h  after  allergen  challenge. At  6h  after
challenge (i.e. after the EAR, but before the initiation
of the LAR; Fig. 2), a significant increase in eosinophil
and neutrophil numbers was observed in the adven-
titia of both large and small airways, while there was
a tendency to an increased eosinophil number in the
bronchial submucosa at this time point. The infiltra-
tion of eosinophils and neutrophils was reduced at
24h  after  challenge,  whereas  a  significant  T-cell
infiltration was observed at this time point both in the
bronchial  adventitia  and  in  the  parenchyma.  The
allergen-induced increase in inflammatory cells was
associated with the development of AHR to histamine,
which,  as  shown  previously  in  this  model,18 was
maximal at 6h after challenge and decreased, but still
significantly  present,  at  24h  after  the  provocation.
The  temporal  association  between  the  degree  of,
mainly  adventitial,  infiltration  of  eosinophils  and
neutrophils and the degree of AHR to histamine at 6
and  at 24h after allergen  challenge  may  indicate a
causal relationship between these events. However,
no  significant  correlations  between  infiltration  of
these cells in  any  of  the airway compartments and
AHR were observed. In addition, the enhanced T-cell
infiltration  at  24h  after  allergen  challenge  was  not
significantly  correlated  with  AHR.  Apart  from  the
relatively  low  number  of  experiments,  this  may
indicate  that other  factors  may  be  involved  in  the
development of allergen-induced AHR.
Likewise, in  human  asthmatics, no or only  weak
correlations were found between AHR and inflamma-
tory  cell  numbers  in  BAL,9,24–27 induced  spu-
tum,9,28–31 and  bronchial  biopsies.9,32–37 However,
inflammatory cells found in BAL or sputum represent
luminal  instead of tissue inflammation, while endo-
bronchial biopsies only provide information about the
inflammatory  response  close  to  the  surface  of  the
proximal  airways  (mucosa  and  submucosa),  so  a
possible relationship between AHR and inflammatory
cells in the airways could be easily overlooked using
these techniques.
Indeed, in  previous studies using  our guinea  pig
model of  allergic  asthma, no significant  correlation
was found between eosinophil and neutrophil num-
bers  in  BAL  and AHR  at  6  and  24h  after  allergen
provocation.18 In this model of acute allergic asthma,
it  was  found  that BAL  eosinophils  and  neutrophils
were increased at 6h after allergen provocation, and
even further increased at 24h after allergen. In the
current study, it was observed that tissue eosinophils
and  neutrophils  peak  at  6h  post-allergen  and  are
reduced at 24h, supporting the idea that these cells
migrate  from  the  tissue  to  the  lumen.  A  similar
relationship between the time course of  tissue and
F. Westerhof et al.
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Table 2. Airway reactivity to inhaled histamine of sensitized guinea pigs at 6 and 24h after saline or ovalbumin inhalation
Group Inhalation Histamine PC100 pre/post inhalation
6h (n) 24h (n)
1 Saline 1.00 ± 0.03 (6) –
Ovalbumin 2.97 ± 0.34† (6) –
2 Saline 0.95 ± 0.06 (4) 1.00 ± 0.09 (4)
Ovalbumin 3.22 ± 0.51† (6) 1.57 ± 0.34*‡ (6)
Airway reactivity is expressed as the ratio of histamine provocation concentration causing 100% increase in pleural pressure (PC100) values
obtained at 24h before, and 6 and 24h after inhalation of saline or ovalbumin. Data represent mean values ± SEM of (n) animals. Group 1, guinea
pigs terminated after the early asthmatic reaction; group 2, guinea pigs terminated after the late asthmatic reaction.
*p < 0.05, † p < 0.01 compared with before treatment, one-way analysis of variance followed by the Student–Newman–Keuls test; ‡ p < 0.05
compared with 6h post-ovalbumin, Wilcoxon signed rank test.luminal infiltration of eosinophils was also found in
another  guinea  pig  study38 and  in  asthmatic
patients.39
In addition to cellular infiltration  in  the different
airway  compartments,  the  activation  state  of  the
infiltrated cells may be an important determinant of
allergen-induced  AHR.  Thus,  in  biopsy  studies  in
patients,  a positive  correlation was  found  between
(activated) EG2+ eosinophils and AHR.34 In addition,
in mild asthmatics, a significant correlation was found
between the AHR to histamine and the concentration
of major basic protein (MBP) in the BAL.25 Accord-
ingly, in our guinea pig model, a possible relationship
between eosinophil activation and AHR was indicated
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FIG. 3. Eosinophil numbers at 6 and 24h after saline control inhalation (sal, open bars) or ovalbumin inhalation (oa, hatched
bars) in different airway compartments. Data represent median values, interquartiles, and 10th and 90th percentiles of four to
six animals. Statistical analysis: * p < 0.01, Mann–Whitney rank sum test.by  the  observation  that  levels  of  eosinophil  per-
oxidase (EPO) in BAL fluid were already enhanced at
6h after allergen challenge.40 Moreover, in the same
model, we have recently observed, in contrast to the
number of BAL eosinophils, that the activation state
of the cells (measured as EPO release) is higher at 6h
after  provocation than  at  24h  after  the  challenge,
while a significant correlation was found between the
increased EPO release from the BAL cells and hista-
mine PC100 values at 6h, but not at 24h, after allergen
provocation (De Boer et al., unpublished results).
A  third  cause  of  possible  dissociation  between
inflammatory  cell  numbers  and AHR  in  asthmatics
could  be  progressive  airway  remodeling,  charac-
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FIG. 4. Neutrophil numbers at 6 and 24h after saline control inhalation (sal, open bars) or ovalbumin inhalation (oa, hatched
bars) in different airway compartments. Data represent median values, interquartiles, and 10th and 90th percentiles of four to
six animals. Statistical analysis: *p < 0.01, Mann–Whitney rank sum test.terized  by  thickening  of  the  basement  membrane,
subepithelial  fibrosis,  and  hypertrophy  and  hyper-
plasia of airway smooth muscle, as occurs in chronic
asthma with persistent airway inflammation.41 In the
presence of these morphological changes, the pres-
ence of particular inflammatory cells in the airways is
not a prerequisite for (baseline) AHR.
Similar  to  the  findings  in  the  present  study,  the
occurrence  of  preferential  adventitial  rather  than
submucosal eosinophilia after allergen challenge has
been  reported previously  in  guinea  pigs.42,43 How-
ever, in the study of Frew et al.,43 tissue eosinophilia
was observed between 17 and 48h after the challenge
instead of after 6h as observed in the present study.
Inflammatory cell distribution and airway reactivity
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FIG. 5. Numbers of CD3
+ cells at 6 and 24h after saline control inhalation (sal, open bars) or ovalbumin inhalation (oa, hatched
bars) in different airway compartments. Data represent median values, interquartiles, and 10th and 90th percentiles of four to
six animals. Statistical analysis: † p < 0.05, Mann–Whitney rank sum test.Lapa  e  Silva  et  al.42 found  no  increase  in  sub-
mucosal  eosinophil  numbers  at  2  and  24h  after
challenge, while adventitial eosinophils were elevated
at  24h  but  not  at  2h  after  allergen  challenge.
Different  sensitization  and  provocation  procedures
may account for the different kinetics of infiltration of
inflammatory cells in  these models compared with
our model. Lapa e Silva  et al.42 used an additional
booster  for  sensitization  and  challenged  by  the
intraperitoneal route instead of the inhalational route.
Frew  et  al.43 sensitized  guinea  pigs  by  inhalation,
challenged  under  protection  of  the  H1 receptor
antagonist mepyramine  and measured airway resist-
ance in a whole-body plethysmograph, while in our
model  measurements  were  performed  under  freely
moving conditions, without antihistamine protection.
Very importantly, we have previously demonstrated
that  mepyramine  treatment  may  affect  allergen-
induced asthmatic reactions, AHR and infiltration of
inflammatory cells.44
In lung  tissue from patients with fatal asthma, as
well as lung specimens from asthmatics obtained at
surgery for lung cancer, adventitial eosinophilia has
also been described. In lung specimens obtained from
patients with asthma, Hamid et al.,45 found greater
numbers of eosinophils in the adventitia as compared
with  the  submucosa  of  airways  with  an  internal
perimeter  greater  than  2mm;  however,  activated
eosinophils  seemed  more  numerous  in  the  sub-
mucosa. In a recent study, Haley et al.46 reported a
difference  in  eosinophil  distribution  between  large
and small airways in lung  tissue from patients who
died  from  status  asthmaticus. As  in  our  study,  the
eosinophilic infiltrate  in the small airways was pre-
dominantly found in the adventitia. On the contrary,
large  airways  predominantly  showed  submucosal
eosinophilia, while both adventitial and submucosal
accumulation was found in our study. However, both
for the adventitial and the submucosal compartments,
the eosinophil infiltration was not significantly differ-
ent between large and small airways in our study. In
line with these results, Carroll et al.15 also found no
difference in eosinophil densities between large and
small  airways  in  the  inner  wall  area  between  the
basement  membrane  and  the  outer  border  of  the
smooth muscle in patients dying from asthma. Since
studies  performed  on  autopsy  material  of  patients
represent  cellular  infiltration  in  a  state  of  chronic
asthma, the relevance of the actual inflammatory cell
counts in  this tissue  in  the contribution to AHR  is
unknown.
Both human and guinea pig studies have indicated
that various mechanisms may be involved in eosino-
phil-induced AHR. Although eosinophilic infiltration
was mainly adventitial and epithelial damage was not
investigated  in  this  study,  it  is  well  known  that
eosinophilic  granular  cationic  proteins  may  cause
epithelial damage, thereby causing enhanced airway
permeability  and  exposing  the  underlying  sensory
nerves, which may lead to enhanced cholinergic and
excitatory  non-adrenergic  non-cholinergic  reflex
activities.47–49 Enhanced  cholinergic  reflex  activity
after  allergen  challenge  may  also  develop  from  a
dysfunction of autoinhibitory prejunctional muscari-
nic  M2 receptors  induced  by  eosinophil-derived
MBP.50–52 In addition, it has recently been established
that eosinophilic  polycations  may  be  involved  in  a
deficiency  of  bronchodilating  NO  in  the  airways,
presumably  by  inhibition  of  cellular  uptake  of
L-arginine, the substrate for NO synthase.53–57 Finally,
it  is  known  that  eosinophil-derived  mediators  like
LTC4 and reactive oxygen species may cause swelling
of the airway tissue by enhanced vascular permeabil-
ity.58 Since  adventitial  eosinophilia  was  most  pro-
nounced, it is tempting to speculate that uncoupling
of the airway smooth muscle from the parenchyma
caused by eosinophil-induced outer wall swelling, as
proposed  by  Lambert  et  al.,59 is  an  important
determinant of the observed AHR.
In  line  with  our  results,  several  studies  have
demonstrated increased neutrophil numbers in BAL
fluid  from  asthmatics  and  from  guinea  pigs  after
allergen  challenge.2,18,38,60 Moreover,  there  are
increasing indications that neutrophils may play a role
in  acute  severe  asthma. Thus, enhanced infiltration
and/or  activation  of  neutrophils  has  been  demon-
strated  in  fatal  asthma  of  sudden  onset,61 status
asthmaticus,62 and during exacerbations of asthma.63
In addition, recent evidence from bronchial biopsies64
and induced sputum65 indicates that neutrophils may
also be involved in severe persistent asthma.
The  role  of  neutrophils  in  the  development  of
allergen-induced  AHR  is  presently  unclear.  Neutro-
phils have the capacity to generate enhanced levels of
superoxide  anion  (O2
–)  in  patients  with  asthma,
which correlates with the airway reactivity to metha-
choline in these patients.66 In the presence of high
concentrations  of  inducible  nitric  oxide  synthase
(iNOS)-derived nitric oxide in the inflamed airways,
O2
– may  cause  formation  of  the  highly  cytotoxic
oxidant  peroxynitrite  (ONOO–),  which  has  been
found  to  induce  AHR.67 Moreover,  ONOO– was
demonstrated to  increase  the  release of  MBP  from
eosinophils  in  tracheal  preparations,67 while  neu-
trophils may also enhance eosinophilic LTC4 produc-
tion.68 In addition, neutrophils may enhance eosino-
phil recruitment and degranulation through secretion
of IL-8.65,69,70
Elevated CD3+ cells were found only at 24h after
allergen provocation, both in the parenchyma and in
the bronchial adventitia. In addition, the number of
CD3+ cells in  the parenchyma was correlated with
AHR.  The  observed  rise  in  CD3+ cells  was  not
associated with a change in CD8+ cells. In the absence
of  a  specific  antibody  directed  against  guinea  pig
CD4+ cells,  the  likely  CD4+ character  of  these
F. Westerhof et al.
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lished. Elevated CD3+CD8– lymphocytes in guinea pig
bronchus, but not parenchyma, were also observed
by Frew et al.43 at 17 and 48h after allergen. CD4+
Th2-lymphocytes could contribute to AHR by activa-
tion of eosinophils by the production of IL-5.71
In conclusion, our findings indicate that, in addi-
tion to (sub-)mucosal inflammation, inflammation in
the adventitia of both large and small airways could be
importantly involved in the development of AHR in a
guinea pig model of acute allergic asthma. Although
investigations  of  the  entire  human  airway  circum-
ference  in  relation  to  allergen-induced  AHR  are
hampered by technical limitations, this finding may
be of importance for asthmatic patients, and merits
further investigation.
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